Q4 2025 earnings call recap: 12% sales growth, margin gains, and 2026 guidance for 7–9% sales & $19.15–$19.85 EPS—read now.

The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is ...

Shares rebound as gold, copper gains buoys miners; Xero, WiseTech dumped on AI jitters; Yancoal soars on Chinese coal boom; Bank of America lifts $A forecast; CBA warns on iron ore. Follow live.

Explore the capital asset pricing model's (CAPM) insights on risk and return, and its strengths and weaknesses to empower your investment choices.